• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用COM - B模型对2型糖尿病患者药物治疗不依从相关因素的定性研究进行最佳拟合框架综合分析。

Best fit framework synthesis of qualitative studies on factors associated with medication nonadherence in people with type 2 diabetes using the COM-B model.

作者信息

Teo Vivien, Weinman John, Yap Kai Zhen

机构信息

Institute of Pharmaceutical Sciences, King's College London, London, UK.

Department of Pharmacy, National University of Singapore, Singapore.

出版信息

Br J Clin Pharmacol. 2025 Jun;91(6):1675-1691. doi: 10.1111/bcp.70059.

DOI:10.1111/bcp.70059
PMID:40441697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12122126/
Abstract

This review aimed to synthesize factors associated with medication nonadherence among people with type 2 diabetes (PwT2D), using the Capability, Opportunity, Motivation and Behaviour (COM-B) model as the a priori model. Studies published between January 2014 and April 2024 were searched on five databases. Studies were included if they recruited PwT2D aged >18 years, investigated factors associated with adherence to oral and/or nonoral medications for diabetes, used qualitative research methods, were conducted in a community setting, were in English language and had accessible full-text articles. Best fit framework synthesis was undertaken, which led to the development of a hypothesized COM-B variant model specific to medication nonadherence among PwT2D. Study quality was assessed using published criteria to evaluate whether the study was adequately reported. Twenty-two studies were included. Factors were mapped onto the COM-B model: physical capability (e.g., difficulty injecting insulin independently), psychological capability (e.g., understanding about diabetes), physical opportunity (e.g., cost of medication), social opportunity (e.g., quality of communication and relationship with healthcare providers), automatic motivation (e.g., habit formation) and reflective motivation (e.g., perceived necessity and effectiveness of medications). Reflective motivation had the most themes, while physical capability only had one theme. Personality was a theme that could not be mapped onto the model. Interactions between some COM-B components (e.g., capability and motivation) were observed. This theoretically grounded synthesis may facilitate future intervention development by formulating a programme theory and identifying behaviour change techniques to address the identified factors.

摘要

本综述旨在综合2型糖尿病患者(PwT2D)药物治疗不依从相关因素,采用能力、机会、动机和行为(COM-B)模型作为先验模型。在五个数据库中检索了2014年1月至2024年4月发表的研究。纳入标准为:招募年龄大于18岁的PwT2D患者,研究与糖尿病口服和/或非口服药物依从性相关的因素,采用定性研究方法,在社区环境中开展,语言为英语且有可获取的全文文章。采用最佳拟合框架综合法,得出了一个特定于PwT2D患者药物治疗不依从的假设COM-B变体模型。使用已发表的标准评估研究质量,以评估研究报告是否充分。共纳入22项研究。将相关因素映射到COM-B模型上:身体能力(如独立注射胰岛素困难)、心理能力(如对糖尿病的了解)、身体机会(如药物成本)、社会机会(如与医疗服务提供者沟通的质量和关系)、自动动机(如习惯形成)和反思动机(如对药物必要性和有效性的认知)。反思动机的主题最多,而身体能力只有一个主题。个性是一个无法映射到该模型上的主题。观察到一些COM-B组件之间的相互作用(如能力和动机)。这种基于理论的综合分析可能通过制定项目理论和确定行为改变技术来解决已识别的因素,从而促进未来干预措施的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3b4/12122126/59936bcc17ae/BCP-91-1675-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3b4/12122126/71995cd0548c/BCP-91-1675-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3b4/12122126/144c06590b44/BCP-91-1675-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3b4/12122126/59936bcc17ae/BCP-91-1675-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3b4/12122126/71995cd0548c/BCP-91-1675-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3b4/12122126/144c06590b44/BCP-91-1675-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3b4/12122126/59936bcc17ae/BCP-91-1675-g002.jpg

相似文献

1
Best fit framework synthesis of qualitative studies on factors associated with medication nonadherence in people with type 2 diabetes using the COM-B model.使用COM - B模型对2型糖尿病患者药物治疗不依从相关因素的定性研究进行最佳拟合框架综合分析。
Br J Clin Pharmacol. 2025 Jun;91(6):1675-1691. doi: 10.1111/bcp.70059.
2
Best fit framework synthesis of qualitative studies on factors associated with medication nonadherence in people with type 2 diabetes using the COM-B model.使用COM-B模型对2型糖尿病患者药物治疗不依从相关因素的定性研究进行最佳拟合框架综合分析。
Br J Clin Pharmacol. 2025 Apr 2. doi: 10.1002/bcp.70059.
3
Barriers and facilitators of benzathine penicillin G adherence among rheumatic heart disease patients: a mixed methods systematic review using the COM-B (capability, opportunity, and motivation for behavior) model.风湿性心脏病患者苄星青霉素G依从性的障碍与促进因素:一项使用COM-B(行为能力、机会和动机)模型的混合方法系统评价
Syst Rev. 2024 Dec 3;13(1):297. doi: 10.1186/s13643-024-02691-1.
4
Application of the COM-B model to barriers and facilitators to chlamydia testing in general practice for young people and primary care practitioners: a systematic review.运用 COM-B 模型分析在年轻人和初级保健医生中进行衣原体检测的一般实践中的障碍和促进因素:系统评价。
Implement Sci. 2018 Oct 22;13(1):130. doi: 10.1186/s13012-018-0821-y.
5
Systematic Review Examining the Behavior Change Techniques in Medication Adherence Intervention Studies Among People With Type 2 Diabetes.系统评价考察了 2 型糖尿病患者药物依从性干预研究中的行为改变技术。
Ann Behav Med. 2024 Mar 12;58(4):229-241. doi: 10.1093/abm/kaae001.
6
Barriers and Facilitators of Adherence to Nicotine Replacement Therapy: A Systematic Review and Analysis Using the Capability, Opportunity, Motivation, and Behaviour (COM-B) Model.尼古丁替代疗法依从性的障碍和促进因素:使用能力、机会、动机和行为 (COM-B) 模型进行的系统评价和分析。
Int J Environ Res Public Health. 2020 Nov 30;17(23):8895. doi: 10.3390/ijerph17238895.
7
Behaviour change and rehabilitation adherence in adults with tendinopathy: a scoping review.成人肌腱病患者的行为改变与康复依从性:一项范围综述
Disabil Rehabil. 2024 Dec;46(25):6021-6033. doi: 10.1080/09638288.2024.2320832. Epub 2024 Feb 29.
8
Type 2 diabetes patients' and providers' differing perspectives on medication nonadherence: a qualitative meta-synthesis.2型糖尿病患者与医疗服务提供者对药物治疗不依从的不同观点:一项定性元分析
BMC Health Serv Res. 2015 Nov 23;15:516. doi: 10.1186/s12913-015-1174-8.
9
The use of the Capability-Opportunity- Motivation Behavior (COM-B) model to identify barriers to medication adherence and the application of mobile health technology in adults with coronary heart disease: A qualitative study.运用能力-机会-动机行为(COM-B)模型识别冠心病成年患者药物依从性的障碍以及移动健康技术的应用:一项定性研究。
PEC Innov. 2023 Sep 7;3:100209. doi: 10.1016/j.pecinn.2023.100209. eCollection 2023 Dec 15.
10
Adapting a Text Messaging Intervention to Improve Diabetes Medication Adherence in a Spanish-Speaking Population: Qualitative Study.调整短信干预措施以提高说西班牙语人群的糖尿病药物依从性:定性研究
JMIR Hum Factors. 2025 May 1;12:e66668. doi: 10.2196/66668.

引用本文的文献

1
Best fit framework synthesis of qualitative studies on factors associated with medication nonadherence in people with type 2 diabetes using the COM-B model.使用COM-B模型对2型糖尿病患者药物治疗不依从相关因素的定性研究进行最佳拟合框架综合分析。
Br J Clin Pharmacol. 2025 Apr 2. doi: 10.1002/bcp.70059.

本文引用的文献

1
Systematic Review Examining the Behavior Change Techniques in Medication Adherence Intervention Studies Among People With Type 2 Diabetes.系统评价考察了 2 型糖尿病患者药物依从性干预研究中的行为改变技术。
Ann Behav Med. 2024 Mar 12;58(4):229-241. doi: 10.1093/abm/kaae001.
2
Prevalence of medication adherence and glycemic control among patients with type 2 diabetes and influencing factors: A cross-sectional study.2型糖尿病患者的药物依从性和血糖控制情况及其影响因素:一项横断面研究。
Glob Epidemiol. 2023 Jun 10;5:100113. doi: 10.1016/j.gloepi.2023.100113. eCollection 2023 Dec.
3
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021.
全球、地区和国家 1990 年至 2021 年糖尿病负担,以及对 2050 年患病率的预测:2021 年全球疾病负担研究的系统分析。
Lancet. 2023 Jul 15;402(10397):203-234. doi: 10.1016/S0140-6736(23)01301-6. Epub 2023 Jun 22.
4
Cardiac Microvascular Dysfunction and Cardiomyopathy in Diabetes: Is Ferroptosis a Therapeutic Target?糖尿病中的心脏微血管功能障碍与心肌病:铁死亡是一个治疗靶点吗?
Diabetes. 2023 Mar 1;72(3):313-315. doi: 10.2337/dbi22-0036.
5
Implementing Sodium-Glucose Cotransporter-2 Inhibitor Therapy for Heart Failure: What Is the Message to DELIVER?实施钠-葡萄糖协同转运蛋白2抑制剂治疗心力衰竭:传递的信息是什么?
J Am Coll Cardiol. 2022 Nov 8;80(19):1785-1787. doi: 10.1016/j.jacc.2022.09.008.
6
Non-adherence to medication and associated factors among type 2 diabetes patients at Clinique Medicale Fraternite, Rwanda: a cross-sectional study.卢旺达 Fraternite 医疗诊所 2 型糖尿病患者的药物不依从性及其相关因素:一项横断面研究。
BMC Endocr Disord. 2022 Aug 31;22(1):219. doi: 10.1186/s12902-022-01133-0.
7
Key factors for overcoming psychological insulin resistance: A qualitative study in Japanese people with type 2 diabetes.克服心理胰岛素抵抗的关键因素:一项针对日本 2 型糖尿病患者的定性研究。
Prim Care Diabetes. 2022 Jun;16(3):411-416. doi: 10.1016/j.pcd.2022.02.009. Epub 2022 Mar 4.
8
Impact of patients' beliefs about insulin on acceptance and adherence to insulin therapy: a qualitative study in primary care.患者对胰岛素的认知对胰岛素治疗接受度和依从性的影响:一项初级保健中的定性研究
BMC Prim Care. 2022 Jan 20;23(1):15. doi: 10.1186/s12875-022-01627-9.
9
Which Aspect of Patient-Provider Relationship Affects Acceptance and Adherence of Insulin Therapy in Type 2 Diabetes Mellitus? A Qualitative Study in Primary Care.医患关系的哪个方面会影响2型糖尿病患者对胰岛素治疗的接受度和依从性?一项初级保健中的定性研究。
Diabetes Metab Syndr Obes. 2022 Jan 26;15:235-246. doi: 10.2147/DMSO.S344607. eCollection 2022.
10
A Qualitative Study on Medication Taking Behaviour Among People With Diabetes in Australia.澳大利亚糖尿病患者用药行为的定性研究
Front Pharmacol. 2021 Sep 20;12:693748. doi: 10.3389/fphar.2021.693748. eCollection 2021.